First Heartland Consultants’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

First Heartland Consultants’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,492	Closed	-$5K	–	339
2016 Q2	$5K	Hold	1,492	–	–	﹤0.01%	302
2016 Q1	$8K	Sell	1,492 -5,970	-80%	-$47.7K	﹤0.01%	269
2015 Q4	$92K	Hold	7,462	–	–	0.03%	264
2015 Q3	$109K	Hold	7,462	–	–	0.05%	246
2015 Q2	$146K	Hold	7,462	–	–	0.04%	249
2015 Q1	$135K	Hold	7,462	–	–	0.05%	243
2014 Q4	$176K	Hold	7,462	–	–	0.07%	232
2014 Q3	$181K	Hold	7,462	–	–	0.08%	234
2014 Q2	$210K	Hold	7,462	–	–	0.09%	227
2014 Q1	$254K	Hold	7,462	–	–	0.13%	196
2013 Q4	$143K	Hold	7,462	–	–	0.08%	189
2013 Q3	$124K	Hold	7,462	–	–	0.07%	215
2013 Q2	$78K	Buy	+7,462	New	+$87.5K	0.05%	248

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Heartland Consultants's CTIC Position: Q3 2016 in Review

First Heartland Consultants sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2016, closing a stake of 1,492 shares — an estimated $5K sold.

First Heartland Consultants first reported a position in CTIC in Q2 2013 and held it in 13 quarters. The position peaked at $254K in Q1 2014. 61 funds tracked by Wall St. Rank hold CTIC as of Q3 2016.

First Heartland Consultants reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2016 after selling out during the quarter.
First Heartland Consultants sold 1,492 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2016, an estimated $5K.
First Heartland Consultants first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 13 quarters.
First Heartland Consultants's CTI BioPharma Corp. (DE) Common Stock position peaked at $254K in Q1 2014.
61 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2016.

Based on First Heartland Consultants's 13F filing for Q3 2016, filed 23 Nov 2016.